ATE90878T1 - Avirulenter tollwut-impfstoff. - Google Patents

Avirulenter tollwut-impfstoff.

Info

Publication number
ATE90878T1
ATE90878T1 AT89401925T AT89401925T ATE90878T1 AT E90878 T1 ATE90878 T1 AT E90878T1 AT 89401925 T AT89401925 T AT 89401925T AT 89401925 T AT89401925 T AT 89401925T AT E90878 T1 ATE90878 T1 AT E90878T1
Authority
AT
Austria
Prior art keywords
avirulent
rabies vaccine
vaccine
avirulent rabies
arginine
Prior art date
Application number
AT89401925T
Other languages
English (en)
Inventor
Anne Flamand
Patrice Coulon
Helene Leblois
Florence Lafay
Marie-Christine Tuffereau
Original Assignee
Virbac Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Sa filed Critical Virbac Sa
Application granted granted Critical
Publication of ATE90878T1 publication Critical patent/ATE90878T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89401925T 1988-07-05 1989-07-05 Avirulenter tollwut-impfstoff. ATE90878T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8809099A FR2633832B1 (fr) 1988-07-05 1988-07-05 Vaccin antirabique avirulent
EP89401925A EP0350398B1 (de) 1988-07-05 1989-07-05 Avirulenter Tollwut-Impfstoff

Publications (1)

Publication Number Publication Date
ATE90878T1 true ATE90878T1 (de) 1993-07-15

Family

ID=9368096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401925T ATE90878T1 (de) 1988-07-05 1989-07-05 Avirulenter tollwut-impfstoff.

Country Status (6)

Country Link
EP (1) EP0350398B1 (de)
AT (1) ATE90878T1 (de)
DE (1) DE68907280T2 (de)
DK (1) DK170393B1 (de)
ES (1) ES2058570T3 (de)
FR (1) FR2633832B1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
ATE356202T1 (de) * 1998-11-27 2007-03-15 Intervet Int Bv Attenuierte stabile tollwutvirusmutante und lebende impfstoffe
CN101287838B (zh) 2005-10-14 2016-03-30 美国政府健康及人类服务部，疾病控制和预防中心 狂犬病病毒组合物和方法
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent

Also Published As

Publication number Publication date
DK331589A (da) 1990-01-06
EP0350398B1 (de) 1993-06-23
ES2058570T3 (es) 1994-11-01
DK170393B1 (da) 1995-08-21
DE68907280D1 (de) 1993-07-29
FR2633832B1 (fr) 1991-05-31
EP0350398A1 (de) 1990-01-10
DE68907280T2 (de) 1993-12-02
FR2633832A1 (fr) 1990-01-12
DK331589D0 (da) 1989-07-04

Similar Documents

Publication Publication Date Title
DK0522341T3 (da) Transparent dentalmateriale
BR9500732B1 (pt) kit diagnóstico para a detecção de anticorpos contra vìrus que causam imunodeficiência.
DE68929467D1 (de) HIV-2 Varianten
EP0203676A3 (en) Vaccine for generating an immunogenic t cell response protective against a virus
ATE47524T1 (de) Hundeparvovirus-impfstoffe.
DE69323130D1 (de) Avirulenter Tollwut-Impfstoff
GR3031889T3 (en) Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines.
DE69018926D1 (de) Vakzine gegen Bordetella.
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
DK627687D0 (da) Hirudinvariant
IL86439A (en) Cyclic anticoagulant peptides
ATE90878T1 (de) Avirulenter tollwut-impfstoff.
EP0310887A3 (en) Vasoconstrictor peptide
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
ATE159758T1 (de) Azelluläre impfstoffe

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee